| Product name | Monoclonal mouse antibody to Chlamydia pneumoniae |
| Clone | 5G5 |
| Ig sub-isotype | IgG 2b |
| Source | Ascitic fluid of tumour bearing BALB/c mice, inoculated with hybridoma clone 5G5 |
| Purification method | Caprylic acid and ammonium sulfate precipitation |
| Purity | more than 95% according to 12% SDS-PAGE |
| Presentation | Solution in PBS, 0.01% Thimerosal |
| Protein concentration | Approx. 1 mg/ml by spectrophotometery |
| Specificity | Specificity was determined in MIF and Indirect ELISA (MEDAC microplate coated with Chlamydia pneumoniae-specific antigen) No activity in Western Blot. |
| Volume | 0.1 ml |
| Quantity | 0.1 mg |
| Storage | min. 6 months at –20oC |
 |
 |
|---|---|
C. pneumoniae |
C. trachomatis |
| Product name | Monoclonal mouse antibody to Chlamydia pneumoniae |
| Clone | 4F3 |
| Ig sub-isotype | IgG 2a |
| Source | Ascitic fluid of tumour bearing BALB/c mice, inoculated with hybridoma clone 4F3 |
| Purification method | Caprylic acid and ammonium sulfate precipitation |
| Purity | more than 95% according to 12% SDS-PAGE |
| Presentation | Solution in PBS, 0.01% Thimerosal |
| Protein concentration | Approx. 1 mg/ml by spectrophotometery |
| Specificity | Specificity was determined in MIF and Indirect ELISA (MEDAC microplate coated with Chlamydia pneumoniae-specific antigen) No activity in Western Blot. |
| Volume | 0.1 ml |
| Quantity | 0.1 mg |
| Storage | min. 6 months at –20oC |
 |
 |
|---|---|
C. pneumoniae |
C. trachomatis |
| Product name | Monoclonal mouse antibody to Chlamydia pneumoniae |
| Clone | 5D9s |
| Ig sub-isotype | IgG 2a |
| Source | Ascitic fluid of tumour bearing BALB/c mice, inoculated with hybridoma clone 5D9 |
| Purification method | Caprylic acid and ammonium sulfate precipitation |
| Purity | more than 95% according to 12% SDS-PAGE |
| Presentation | Solution in PBS, 0.1% Thimerosal |
| Protein concentration | Approx. 1 mg/ml by spectrophotometery |
| Specificity | Specificity was determined in MIF and Indirect ELISA (MEDAC microplate coated with Chlamydia pneumoniae-specific antigen) No activity in Western Blot. |
| Volume | 0.1 ml |
| Quantity | 0.1 mg |
| Storage | min. 6 months at –20oC |
 |
 |
|---|---|
C. pneumoniae |
C. trachomatis |
| Product name | Cross-reactive monoclonal mouse antibody to Chlamydia spp. LPS and Human ApoB/ApoE |
| Clone | 6C/C5 |
| Ig sub-isotype | IgG 1 |
| Source | Ascitic fluid of tumour bearing BALB/c mice, inoculated with hybridoma clone 6C/C5 |
| Purification method | Caprylic acid and ammonium sulfate precipitation |
| Purity | more than 95% according to 12% SDS-PAGE |
| Presentation | Solution in PBS, 0.1% Thimerosal |
| Protein concentration | Approx. 1 mg/ml by spectrophotometery |
| Specificity | Specificity to Chlamydia spp. LPS was determined in MIF and Western Blot; Specificity to ApoB/ApoE was determined in ELSIA |
| Volume | 0.1 ml |
| Quantity | 0.1 mg |
| Storage | min. 6 months at –20oC |
 |
|---|
C. pneumoniae |
© Copyright Cambridge Theranostics 2008.
Cambridge Theranostics Ltd. Registered in England and Wales No: 4314866; Registered office: 7 Hills Avenue, Cambridge CB1 7UY